XML 13 R34.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2020
Segment Reporting  
Schedule of reportable operating segment information

​

​

​

​

​

​

​

​

​

​

​

​

​

CareVention HealthCare

​

MedWise HealthCare

​

Consolidated

Revenue:

​

​

​

​

​

​

​

​

​

Three Months Ended March 31, 2020

​

​

​

​

​

​

​

​

​

Product revenue

​

​

37,087

​

​

—

​

​

37,087

Service revenue

​

​

​

​

​

​

​

​

​

PACE solutions

​

​

11,571

​

​

—

​

​

11,571

Medication safety services

​

​

—

​

​

14,320

​

​

14,320

Software subscription

​

​

—

​

​

9,849

​

​

9,849

Total service revenue

​

​

11,571

​

​

24,169

​

​

35,740

Total revenue

​

$

48,658

​

$

24,169

​

$

72,827

​

​

​

​

​

​

​

​

​

​

Three Months Ended March 31, 2019

​

​

​

​

​

​

​

​

​

Product revenue

​

​

30,982

​

​

—

​

​

30,982

Service revenue

​

​

​

​

​

​

​

​

​

PACE solutions

​

​

11,174

​

​

—

​

​

11,174

Medication safety services

​

​

—

​

​

15,351

​

​

15,351

Software subscription

​

​

—

​

​

3,452

​

​

3,452

Total service revenue

​

​

11,174

​

​

18,803

​

​

29,977

Total revenue

​

$

42,156

​

$

18,803

​

$

60,959

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

CareVention HealthCare

​

MedWise HealthCare

​

Shared Services

​

Consolidated

Adjusted EBITDA (loss):

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended March 31, 2020

​

​

​

​

​

​

​

​

​

​

​

​

Adjusted EBITDA (loss)

​

$

11,748

​

$

2,831

​

$

(9,772)

​

$

4,807

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended March 31, 2019

​

​

​

​

​

​

​

​

​

​

​

​

Adjusted EBITDA (loss)

​

$

10,620

​

$

1,648

​

$

(6,577)

​

$

5,691

Schedule of reconciliation of the segments? total Adjusted EBITDA to net loss

​

​

​

​

​

​

​

​

Three Months Ended March 31, 

​

2020

    

2019

Reconciliation of net loss to Adjusted EBITDA

​

​

​

​

​

Net loss

$

(14,437)

​

$

(10,979)

Add:

​

​

​

​

​

Interest expense, net

​

4,610

​

​

2,693

Income tax benefit

​

(3,367)

​

​

(4,041)

Depreciation and amortization

​

9,913

​

​

6,299

Change in fair value of acquisition-related contingent consideration expense

​

700

​

​

1,176

Acquisition-related expense

​

251

​

​

3,691

Stock-based compensation expense

​

7,137

​

​

6,852

Adjusted EBITDA

$

4,807

​

$

5,691